Credit Suisse lowered its target price for Innovent (01801) to HK$52 from HK$57 and maintained its "outperform" rating.
The research house said it now estimates FY23 topline growth at 33%. After model adjustment, the FY23/24E EPS is lower by 15%/59%.
全新節目《說說心理話》青少年不可以戀愛！？真實個案講述驚心動魄經歷► 即睇
